What's in Novaliq GmbH's pipeline?

Novaliq GmbH has 6 drugs in our index: 2 marketed, 0 filed, 3 in Phase 3, 0 in Phase 2, 1 in Phase 1.

Which companies overlap with Novaliq GmbH's portfolio?

Top competitors by shared drug class: Albert Einstein Healthcare Network, Allergan, Andrew B Adams, Armando Torres Ramírez, Assistance Publique - Hôpitaux de Paris.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/novaliq-gmbh.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

Novaliq GmbH — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Novaliq GmbH pipeline: 2 marketed, 0 filed, 3 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

2 marketed 0 filed 3 Phase 3 0 Phase 2 1 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
Saline solution, 0.6%	Saline solution, 0.6%	marketed	Osmotic agent / Ophthalmic decongestant		Ophthalmology
Cyclosporine ophthalmic solution, 0.1%	Cyclosporine ophthalmic solution, 0.1%	marketed	Calcineurin inhibitor	Calcineurin	Ophthalmology
CyclASol topical ocular, eye drops	CyclASol topical ocular, eye drops	phase 3	Calcineurin inhibitor	Calcineurin	Ophthalmology
CyclASol Ophthalmic Solution	CyclASol Ophthalmic Solution	phase 3	Calcineurin inhibitor	Calcineurin	Ophthalmology
Vehicle topical ocular, eye drops	Vehicle topical ocular, eye drops	phase 3			Ophthalmology

Therapeutic area mix

Ophthalmology · 5

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Albert Einstein Healthcare Network · 1 shared drug class
Allergan · 1 shared drug class
Andrew B Adams · 1 shared drug class
Armando Torres Ramírez · 1 shared drug class
Assistance Publique - Hôpitaux de Paris · 1 shared drug class
Astellas Pharma China, Inc. · 1 shared drug class
Astellas Pharma Europe Ltd. · 1 shared drug class
Al-Azhar University · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Novaliq GmbH:

Cite this brief

Drug Landscape (2026). Novaliq GmbH — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/novaliq-gmbh. Accessed 2026-05-16.